. Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am J Physiol Gastrointest Liver Physiol 280: G264-G272, 2001.-Previous studies found that monolayers formed from canine oxyntic epithelial cells in primary culture displayed remarkable resistance to apical acidification and both mitogenic and migratory responses to epidermal growth factor (EGF) treatment. In our present studies, we found that EGF increased transepithelial resistance (TER) but not shortcircuit current in these monolayers. Parallel effects of EGF on decreasing mannitol flux and increasing TER implicate direct regulation of paracellular permeability. EGF acting at either apical and basolateral receptors rapidly increased TER, but the apical response was sustained whereas the basolateral response was transient.
Chen, Monica C., Jeffrey Goliger, Nigel Bunnett, and Andrew H. Soll. Apical and basolateral EGF receptors regulate gastric mucosal paracellular permeability. Am J Physiol Gastrointest Liver Physiol 280: G264-G272, 2001.-Previous studies found that monolayers formed from canine oxyntic epithelial cells in primary culture displayed remarkable resistance to apical acidification and both mitogenic and migratory responses to epidermal growth factor (EGF) treatment. In our present studies, we found that EGF increased transepithelial resistance (TER) but not shortcircuit current in these monolayers. Parallel effects of EGF on decreasing mannitol flux and increasing TER implicate direct regulation of paracellular permeability. EGF acting at either apical and basolateral receptors rapidly increased TER, but the apical response was sustained whereas the basolateral response was transient. 125 I-labeled EGF binding revealed specific apical binding, but receptor numbers were 25-fold lower than on the basolateral surface. Both apical and basolateral EGF activated tyrosine phosphorylation of EGF receptors (EGFR), ␤-catenin, and cellular substrate as evident on confocal microscopy. Although apical EGF activated a lesser degree of receptor autophosphorylation than basolateral EGF, phosphorylation of ␤-catenin was equally prominent with apical and basolateral receptor activation. Together, these findings indicate that functional apical and basolateral EGFR exist on primary canine gastric epithelial cells and that these receptors regulate paracellular permeability. The sustained effect of apical EGFR activation and prominent phosphorylation of ␤-catenin suggest that apical EGFR may play a key role in this regulation.
epidermal growth factor receptors; transforming growth factor receptors; gastric mucosal defense; paracellular pathway EPIDERMAL GROWTH FACTOR (EGF) is a 53-amino acid polypeptide that regulates the proliferation and differentiation of a variety of cell types, including polarized epithelial cells. EGF is present in salivary glands, duodenal Brunner's glands, and mucosal epithelial cells after injury (1, 28, 36) . Several other EGF family members are present in gastric mucosa, including transforming growth factor-␣ (TGF-␣), which is found in parietal cells (2, 5) . Other members of the EGF family present in gastrointestinal mucosa include amphiregulin and heparin-binding EGF (1, 20) .
EGF peptide family members are endogenous to the apical and basolateral gastric environment. These endogenous peptides appear to enhance mucosal repair, healing, and resistance to injury (6, 13, 17, 26) . EGF itself is secreted at the luminal surfaces of salivary glands and duodenal Brunner's glands and is present in milk (3, 13) . In addition, EGF is relatively stable in gastric juice, although some degradation occurs to smaller forms that retain moderate physiological activity (24) . The physiological importance of luminal EGF is supported by observations (18, 21, 25, 31 ) that removing submandibular glands enhances susceptibility of the gastric mucosa to injury, whereas adding exogenous luminal EGF has protective effects. These data provide indirect evidence that functional EGF receptors (EGFR) are present on the luminal surface of gastric cells, where they appear to regulate aspects of mucosal defense and repair. However, it is also possible that EGF undergoes translocation to basolateral receptors (29) .
Although it is clear that EGF acts predominantly at the basolateral surfaces of polarized epithelia, several lines of evidence indicate that EGF can also act at apical surface receptors. Low amounts (2-15%) of EGF total binding activity have been detected on the apical surfaces of several cultured cell lines (14, 15) . Studies have focused on the classical EGFR, which is a 170-kDa transmembrane glycoprotein composed of an extracellular ligand binding domain and a cytoplasmic tyrosine kinase domain. EGFR have been immunohistochemically detected on the apical membranes of compacted eight-cell stage mouse embryos, trophoblastic cells from human placenta, and injured or diseased kidney cells (12, 34) . However, the stability, receptor activation, and functional consequences of apical EGFR remain unclear. Model systems are limited for investigating apical receptors.
In our present studies, we have used a primary culture model of polarized canine gastric mucosal cells to examine the effects of EGF on paracellular permeability and to investigate the presence and functions of apical EGFR. In previous studies (4), we found these monolayers to display marked resistance to apical but not basolateral acidification, thus mimicking an important property of mucosal defense in vivo (27) . We (4) further showed that apical acidification increased transepithelial resistance (TER) and decreased mannitol flux, indicating that the paracellular pathway was a critical point of resistance to apical acid. We now show that functional EGFR are located on the apical, as well as basolateral, surfaces of primary gastric mucosal cells and that both apical and basolateral EGFR mediate ligand-induced decreases in paracellular permeability and tyrosine phosphorylation of apical junction proteins. and then switched to serum-free medium for an additional 6 h as described in METHODS. A: EGF (5 nM) was added to either the apical (AP) or basolateral (BL) surface at t ϭ 0. Control monolayers were treated with vehicle only. TER was measured with an EVOM at indicated times after addition of EGF. Data represent means Ϯ SE from 5 experiments using separate cell preparations. B: mannitol flux was measured in parallel monolayers pretreated for 30 min (EGF added at t ϭ Ϫ0.5 h) with 20 nM EGF on the apical or basolateral surface; control monolayers were pretreated with vehicle only. The initial TER response to EGF or vehicle was recorded and [ 3 H]mannitol was added to the apical solution at t ϭ 0, and aliquots of basolateral solution were assayed for radioactivity at indicated times. Mannitol flux is expressed as counts ⅐ minute (cpm) Ϫ1 ⅐ aliquot
Ϫ1
. Data are means of 3 replicate wells and are representative of experiments using 3 separate cell preparations. First-order linear regressions were performed with Sigma Plot software to calculate average rates of flux (all values for r 2 Ͼ0.98). C: mannitol flux was measured as described in B with parallel monolayers pretreated for 120 min with 20 nM EGF added at t ϭ 0 on the apical or basolateral surface; control monolayers were pretreated with vehicle only. The initial TER response to EGF or vehicle was recorded and [ 3 H]mannitol was added to the apical solution at t ϭ 2. D: average initial flux rates (over the first 2.5 h after adding mannitol) for the individual monolayers depicted in B were plotted against the reciprocal of their TER measured at t ϭ 0 (30 min after the addition of EGF or vehicle). The linear relationship (r 2 ϭ0.85) indicates that EGF-dependent changes in TER are predominantly due to changes in paracellular permeability.
METHODS

Materials.
Materials for cell culture were obtained from sources outlined previously (6) . Transwell inserts were from Costar (Cambridge, MA).
125 I-labeled EGF and 125 I-labeled TGF-␣ were purchased from Biomedical Technology (Stoughton, MA), and human recombinant EGF was from R&D Systems (Minneapolis, MN). Anti-EGFR antibody MAb528 (Ab-1) was purchased from Oncogen Science (Cambridge, MA). An epithelial voltohmmeter (EVOM) Millicell-ERS was from Millipore (Bedford, MA). Affinity-purified rabbit anti-ZO-1 was from Zymed Laboratories (San Francisco, CA). Anti-phosphotyrosine (monoclonal IgG 2bk ) and agarose-conjugated anti-phosphotyrosine were from Upstate Biotechnology (Lake Placid, NY). A monoclonal antibody phosphotyrosine-PY 20 used in the Western blot and anti-␤-catenin (mouse IgG1) were from Transduction Laboratories (Lexington, KY). Other chemicals were from Sigma Chemical (St. Louis, MO).
Tissue dispersion, cell separation, and culture. Enzymedispersed canine oxyntic mucosal cells were separated by elutriation and cultured on collagen-coated Transwell filter inserts (6 or 12 well; Costar), as described previously (4) (5) (6) . When cells became confluent cultures, they contained predominantly chief cells (ϳ55%) and parietal cells (ϳ25%), as indicated by immunologic detection of pepsinogen and H ϩ -K ϩ -ATPase, respectively (18) . The remaining ϳ10% of the cells are likely to be surface and mucous neck cells, proliferative cells, and occasional endocrine cells. Cells were cultured in DMEM-Ham's F-12 (1:1) plus 20 mM HEPES, 100 g/ml amikacin, 100 U/ml penicillin, 100 g/ml streptomycin, and 2% calf serum. Cultures were fed with the same medium every 48 h until confluent (ϳ72 h). Monolayers were switched to serum-free medium (R 0 ) for 6-16 h before growth factor studies were performed.
Electrophysiological measurement of TER. Monolayer TER was monitored using an EVOM with chopstick electrodes. This technique allows repeated measurements of monolayer TER in a sterile condition for a prolonged period of time.
Comparative studies using Ussing chambers as described previously (4) were selectively performed to ensure that similar results were obtained with both methods.
Mannitol flux. Apical-to-basolateral mannitol flux was determined by adding [ 3 H]mannitol to the apical medium as described previously (4) . Aliquots from the basolateral medium at the indicated time intervals were sampled to determine the radioactivity.
125 I-EGF binding. Binding studies were performed on monolayers with TER Ͼ2,500 ⍀ ⅐ cm 2 as described previously (5).
125 I-EGF was added either apically or basolaterally, as indicated, in the absence or presence of various dilutions of either cold EGF or monoclonal EGFR antibody MAb528. Unless otherwise mentioned, MAb528 at the concentration of 20 nM (1:25 dilution of the stock) was used in the studies. Binding was performed at 37°C for 45 min. At the end of binding, aliquots from the counterlateral side of the 125 I-EGF label were taken to determine the amount of label crossing the monolayers. After extensive washing of the monolayers, membranes were cut off from the inserts, and the radioactivity was counted in a gamma counter. The total binding was determined after subtracting the membrane blank (tracer incubated with filter without cells) and expressed as the percentage of maximal binding. 125 I-EGF binding studies were also studied at 4°C for 2, 4, and 8 h of incubation.
I-TGF-␣ binding.
Selective binding studies were repeated with 125 I-TGF-␣ label. The binding conditions were the same as those for 125 I-EGF binding studies.
Immunostaining of junctional tyrosine phosphorylation.
Monolayers were either treated with MAb528 or with apical EGF before paraformaldehyde (3.7%) fixation. Cells were coincubated with primary antibodies specific for ZO-1 (rabbit polyclonal, 1:1,000; Zymed) and phosphotyrosine (monoclonal, 1:50; Upstate Biotechnology) and then immunofluorescently stained using corresponding FITC-(1:200, Jackson ImmunoResearch Laboratories, West Grove, PA) and tetramethylrhodamine isothiocyanate-conjugated secondary antibodies (1:50, Vector Laboratories, Burlingame, CA). Confocal microscopy (MRC1000, Bio-Rad Laboratories, Hercules, CA) was used to better visualize the apical tyrosine phosphorylation. Photomicrographs were generated by superimposing three adjacent horizontal (Z) optical sections of 0.5-to 1.0-m thickness centered on the section displaying the most intense signal for the apical junctional marker ZO-1.
Immunoprecipitation and Western blot. EGF-mediated tyrosine phosphorylation of the EGFR and ␤-catenin was assessed using immunoprecipitation and Western blot. Monolayers were placed in serum-free medium overnight and then apically or basolaterally treated with EGF for 0-20 min. Cells were washed with ice-cold PBS containing phenylmethylsulfonyl fluoride (PMSF) (1 mM) and sodium vanadate (100 M). Cells were then lysed in buffer A [50 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1.5 mM MgCl 2 , 10 mM EDTA, 10% glycerol, and protease and phosphatase inhibitor cocktails (10 g/ml aprotinin and leupeptin, 1 mM PMSF, 1 mM Na 3 VO 4 , 100 M p-nitrophenylphosphate, and 10 mM NaF)] for 30 min in a cold room. Soluble proteins were immunoprecipitated with antiphosphotyrosine antibodies bound to protein A/G-agarose beads (4G10, Upstate Biotechnology). Precipitated proteins were resuspended in sample buffer, resolved by SDS-PAGE (Novex Electrophoresis, San Diego, CA), transferred to nitrocellulose membranes (BioRad Laboratories), and probed with primary antibodies to antiphosphotyrosine (PY20, Transduction Laboratories) to detect EGFR or with antibody to ␤-catenin (Transduction Laboratories). Immunoreactive bands were visualized by enhanced chemiluminescence (Amersham International) with horseradish peroxidase-conjugated secondary antibodies (Bio-Rad Laboratories).
Data analysis. Kinetic binding data were analyzed using GraphPad Prism nonlinear regression software programs (San Diego, CA). Results are expressed as means Ϯ SE. Statistical significance of differences between mean values was assessed using the Student's paired t-test with P Ͻ 0.05 (Statistix, NH Analytical, Roseville, MN).
RESULTS
EGF-mediated regulation of TER and paracellular permeability.
Canine oxyntic cells were cultured on Transwell filters until confluent. When the TER was Ͼ1,000 ⍀ ⅐ cm 2 , monolayers were switched to serumfree medium for at least 6 h before growth factor studies were performed. Monolayers were exposed to 5 nM EGF at either the apical or basolateral surface.
Both treatments resulted in detectable increases in TER within 2 min after adding EGF (Fig. 1A) and a maximal 150-200% increase in TER within 30 min. Basolateral addition consistently evoked greater increases in TER than apical addition. However, the response to basolateral EGF was transient; TER returned to baseline within 2-3 h with basolateral treatment, whereas the effects of apical EGF were relatively stable over an experimental period of several hours.
Mannitol flux experiments were performed on a parallel set of cell cultures to further characterize EGFdependent changes in paracellular permeability. Apical EGF (20 nM) decreased [ 3 H]mannitol flux across monolayers by ϳ50% compared with untreated controls, with this effect sustained for a 7-h period (Fig.  1B) . Basolateral EGF produced a similar, statistically significant decrease in mannitol flux over the first 3 h after treatment (Fig. 1B) . However, between 3 and 7 h after basolateral EGF treatment, mannitol flux increased and was not significantly different from control (P Ͼ 0.5; n ϭ 4; Fig. 1B ). We suspected that the return of mannitol flux rates toward control level 3 h after treatment with basolateral EGF reflected the transient nature of EGF-induced increase in TER with basolateral treatment (Fig.  1A ). This hypothesis was tested by adding [ 3 H]mannitol 2 h after addition of EGF, a time at which TER with basolaterally treated monolayers had returned to near baseline. Under these conditions, basolaterally treated monolayers displayed control rates of mannitol flux, whereas apically treated monolayers displayed the decreased flux rates (Fig. 1C) (Fig. 1B) .
The relationship between 1/TER and mannitol flux is shown in a scatter graph (Fig. 1D) . The inverse linear relationship (r 2 ϭ0.85) between TER measured 30 min after addition of EGF and mannitol flux rates during the 2 h after [ 3 H]mannitol addition suggests that EGFdependent changes in TER are predominantly caused by changes in paracellular permeability.
Inhibition of EGF effects by immunoblocking EGFR with monoclonal antibody MAb528.
We also investigated the effects of blocking EGF-induced increases in TER by anti-receptor antibodies. In previous studies with canine epithelial monolayers plated in plastic culture dishes, we (18) found that the immunoblocking monoclonal antibody against the human EGFR (MAb528) totally inhibited TGF-␣-stimulated thymidine incorporation and migration but did not reduce the effects of cytokines unrelated to EGF. Figure 2 illustrates that ipsilateral (same side) addition of MAb528 (1:25 dilution) suppressed increases in TER induced by low doses (1 nM) of either apical or basolateral EGF. These immunoblocking effects of MAb528 were surmounted by higher doses (50 nM) of EGF (Fig.  2 ). MAb528 at a 1:25 dilution appeared somewhat more effective in blocking basolateral than apical receptormediated increases in TER. Monoclonal antibody against somatostatin CURE S6 (7, 35) at a similar dose did not alter TER effects of either apical or basolateral EGF treatments. Thus apical and basolateral receptors immunologically related to the human EGFR mediate ligand-dependent increases in TER.
Binding of 125 I-EGF to apical and basolateral sites. We (5) previously reported that both 125 I-EGF and 125 I-TGF-␣ bound to gastric epithelial monolayers in plastic culture plates. We now find that 125 I-EGF specifically bound to high-affinity binding sites on both apical and basolateral surfaces of monolayers grown on Transwell inserts. The binding to both surfaces was blocked by ipsilateral, but not contralateral, addition of MAb528 (Fig. 3, A and B) . At the end of the 45-min binding experiment, only 0.26 Ϯ 0.04% (mean Ϯ SE; n ϭ 4) of 125 I radioactivity was detected in the contralateral bathing medium, indicating that apical and basolateral membrane domains were completely separate and that EGF was not translocated to the contralateral surface under these conditions. We found Fig. 4 . Apically applied EGF induces apical and junctional tyrosine phosphorylation. Confocal microscopy was used to visualize EGF-dependent increases in apical tyrosine phosphorylation. Gastric epithelial cell monolayers were treated either with MAb528 for ϳ18 h (A) or with 50 nM EGF for 20 min (B) and then fixed with paraformaldehyde. Cells were coincubated with primary antibodies specific for ZO-1 and phosphotyrosine and then immunofluorescently stained using corresponding FITC-and tetramethylrhodamine isothiocyanate (TRITC)-conjugated secondary antibodies. A and B each show 3 photomicrographs displaying separate stainings for ZO-1 (top, green FITC signal) and phosphotyrosine (middle, red TRITC signal), as well as costaining for both (bottom). Photomicrographs were generated by superimposing three adjacent horizontal (Z) optical sections of 0.5-to 1.0-m thickness, centered on the section displaying the most intense signal for the apical junctional marker ZO-1. Coincidental staining of ZO-1 and phosphotyrosine seen in the bottom photomicrograph of B (as yellow staining) indicates strong tyrosine phosphorylation in EGF-treated monolayers.
that basolateral EGFR specifically bound ϳ25-fold more 125 I-EGF than apical receptors (10,000 Ϯ 4,300 vs. 390 Ϯ 120 counts ⅐ min Ϫ1 ⅐ filter
Ϫ1
; mean Ϯ SE; n ϭ 3). This low proportion of apical to total EGFR is similar to reports (14, 15) for other cell types.
Competition experiments with unlabeled EGF suggested that both basolateral and apical receptors had similar affinity for EGF (dissociation constant ϭ 70 Ϯ 34 and 150 Ϯ 47 pM, respectively; Fig. 3C ; mean Ϯ SE; n ϭ 4). Apical EGFR binding displayed a higher proportion of nonspecific binding than basolateral EGFR, a finding reflecting the much lower total apical binding. In addition, MAb528 appeared to be less effective in displacing EGF from apical than basolateral binding sites (compare Fig. 3, A and B) ; however, proportionate displacement is comparable if nonspecific binding is subtracted.
125 I-TGF-␣ binding was also studied. TGF-␣ binding to apical and basolateral surfaces reflected the same relative magnitude as 125 I-EGF binding (Fig. 3, D and  E) . With the 125 I-TGF-␣ tracer used, the absolute level of apical binding was somewhat lower.
125 I-EGF binding was also studied at 4°C for 2-, 4-, and 8-h incubation periods. Maximal and specific binding was comparable to that reported at 37°C for 45 min (n ϭ 3, data not shown).
Apical EGF induces apical and junctional tyrosine phosphorylation. We next examined protein tyrosine phosphorylation in response to apical EGF treatment (Fig. 4) . Cells exposed to apical EGF for 20 min were colabeled with antibodies against phosphotyrosine and antibodies against the tight junction protein ZO-1 to mark the apical/basolateral membrane interface. Immunofluorescent confocal microscopy revealed marked increases in apical and perijunctional tyrosine phosphorylation in response to apical EGF (Fig. 4B ) compared with control cells (Fig. 4A) . Enhanced tyrosine phosphorylation was detected in most but not all cultured cells, suggesting that within this mixed cell model, not all cell types respond equally to apical EGF treatment. Nevertheless, these results provide further evidence that apical EGFR are functional and stimulate tyrosine kinase activity on ligand binding. In these experiments, control cells (Fig. 4A) were treated with MAb528 to reduce background signals due to endogenous secretion of TGF-␣ by parietal cells (5) . However, we also detected increased tyrosine phosphorylation in EGF-treated cells compared with cells not exposed to MAb528 (data not shown, n ϭ 3). Although we focused our studies on the apical region, as marked by ZO-1, phosphorylation at deeper sites within cells was also evident. We did not detect changes in ZO-1 intensity among control, EGFR-blocked, or apically EGF-treated monolayers.
We further compared the ability of apical and basolateral receptors to mediate EGF-dependent tyrosine phosphorylation of two specific target proteins, the EGFR itself (autophosphorylation) and ␤-catenin, a component of the adherens junction. Immunoprecipitation and Western blot experiments showed that both apical and basolateral treatment with EGF stimulated phosphorylation of a 180-kDa band as early as 1-2 min after ligand addition (Fig. 5A) . However, basolateral treatment resulted in markedly greater EGFR autophosphorylation (8-fold increase) compared with apical treatment (2-fold increase; Fig. 5B ). This is consistent with the relative amounts of EGFR present on each surface (see Fig. 3 ). We confirmed that this band in Fig.  5A was EGFR by immunoprecipitating with the MAb528 and probing Western blots for tyrosine phosphorylation (n ϭ 2, data not shown).
In contrast, despite the wide differences in EGFR numbers on apical and basolateral surfaces, ␤-catenin was comparably tyrosine phosphorylated in response to apical and basolateral addition of EGF (Fig. 6, A  and C) . Neither basolateral nor apical treatment of EGF altered the total amount of ␤-catenin (Fig. 6, B  and D) . A: anti-phosphotyrosine blot of EGFR at various time points after addition of apical or basolateral EGF (20 nM). Soluble lysates were immunoprecipitated with antiphosphotyrosine antibodies bound to protein A/G-agarose beads (4G10), and the membrane was blotted with another antiphosphotyrosine antibody PY20. This 180-kDa band was further verified using MAb528 for the western blot. The results shown are representative of 3 independent preparations. B: quantification of apical and basolateral stimulated EGFR tyrosine phosphorylation. The autoradiograms shown in A were analyzed using the NIH Image program, and the intensity of the specific bands was expressed in densitometry units (%basal). Values are means Ϯ SE from 3 separate preparations. * P Ͻ 0.05, ** P Ͻ 0.01 vs. basal.
DISCUSSION
Our data demonstrate that exogenous EGF at the physiological concentrations added to the apical or basolateral surface of canine gastric monolayers in primary culture causes a rapid increase in TER and a corresponding fall in paracellular permeability, as evidenced by reduced mannitol flux. The tight linear relationship between 1/TER and mannitol flux supports the conclusion that changes in paracellular permeability underlie changes in TER under these conditions and that EGF-induced change in TER reflects direct effects on paracellular permeability.
The response to apical EGF was stable for hours. In contrast, the response to basolateral EGF was transient, returning to baseline after ϳ2 h. It is unclear why the effects of EGF on TER and mannitol flux are more stable with apical compared with basolateral treatment. It is possible that EGF is more rapidly internalized and degraded at basolateral EGFR or that downregulation of EGFR is more prominent at basolateral receptors. Regardless, the temporal correlation, evident by sustained apical and transient basolateral EGFR effects on both TER and mannitol flux, further supports the conclusion that increases in TER reflect decreased paracellular permeability.
Our data provide several lines of evidence supporting the existence of EGFR on the apical surface of these monolayers that are closely related to classical EGFR. 125 I-EGF specifically bound to sites on the apical surface. However, these apical sites were sparse compared with basolateral receptors. Immunoblockade of EGFR by the anti-human EGFR antibody MAb528 displaced binding from both apical and basolateral sites. In addition, MAb528 blocked EGF-induced increases in TER at both apical and basolateral receptors. Anti-EGFR treatment inhibited the effects of low concentrations of EGF on TER, and this inhibition could be surmounted by higher concentrations of EGF. Apparent differences in MAb528 blockade of apical binding reflected the high proportion of nonspecific binding to the lower concentration of apical receptors. Taken together, these findings indicate that apical EGFR are present on these monolayers and that they are closely related to basolateral EGFR. Although mechanisms were not elucidated, studies (19) using polarized kidney epithelial cells with overexpressed apical EGFR demonstrated differences in EGFR downregulation and endocytosis between basolateral and apical EGFR. Studies of internalization would be difficult on our monolayers because of the low concentrations of apical EGFR.
Controls indicated that the apical and basolateral compartments of these culture inserts were functionally separated. Ipsilateral but not contralateral addition of MAb528 inhibited EGF binding to basolateral and apical receptors, respectively. Furthermore, the 125 I-EGF tracer did not significantly cross the monolayer in these culture inserts.
It is well established that protein tyrosine phosphorylation mediates activation by EGFR, a process initiated by autotyrosine phosphorylation of EGFR itself (23) . Tyrosine phosphorylation of EGFR substrates involved in the mitogenic pathway (SHC, ERK1, and ERK2) was detected in response to both apical and basolateral EGFR activation in fibroblast and polar- Fig. 6 . EGF-mediated tyrosine phosphorylation of ␤-catenin. A: experiments were performed as described in Fig. 5 except that the membranes were blotted with antibody to ␤-catenin. B: soluble lysates were immunoprecipitated with antibody to ␤-catenin, and the nitrocellulose membrane was blotted with antibody to ␤-catenin. The results shown here are representative of 3 independent preparations. Quantification of apical and basolateral stimulated tyrosine phosphorylation of ␤-catenin and total ␤-catenin is shown in C and D, respectively. Data are means Ϯ SE from 3 preparations. * P Ͻ 0.05, ** P Ͻ 0.01 vs. basal.
ized epithelial cells (9, 19, 22) . These data suggest that in some experimental models for the mitogenic response to EGF apical EGFR may activate similar pathways to basolateral EGFR.
Although tyrosine phosphorylation has been proposed to play a role in tight junction regulation, supporting evidence remains limited. Selective protein kinase and tyrosine phosphatase inhibitors have been observed to alter protein phosphorylation, junction morphology, and paracellular permeability (8, 11, 33) , but the specificity of these effects is controversial.
We used immunohistochemistry to study the effects of EGF on tyrosine-phosphorylated proteins (32) . Confocal microscopy of monolayers grown on filter inserts revealed a typical apical junctional pattern with antibodies to ZO-1. The addition of EGF did not obviously alter the intensity or distribution of ZO-1 staining. In control monolayers or monolayers treated with MAb528, anti-phosphotyrosine antibodies detected proteins scattered throughout the cell. However, after treatment with apical or basolateral EGF, confocal microscopy indicated early, marked enhancement of apical and perijunctional tyrosine phosphoprotein immunoreactivity. Induction of tyrosine phosphorylation by apical EGFR activation provided additional evidence for the biological activity of these apical receptors.
We also used immunoprecipitation and Western blotting to study tyrosine phosphorylation of EGFR and ␤-catenin (16) in response to apical and basolateral EGFR activation. Autophosphorylation of the 180-kDa EGFR was found with both apical and basolateral EGF treatment. However, basolateral EGFR activation produced much more pronounced receptor autophosphorylation, reflecting the greater number of basolateral EGFR.
Apical and basolateral EGF treatment also induced tyrosine phosphorylation of the 92-kDa ␤-catenin protein. Despite the considerable difference in receptor density and autophosphorylation between apical and basolateral EGF treatment, apical and basolateral EGFR activation produced a roughly comparable degree of phosphorylation of ␤-catenin. These findings showing that apical EGFR activation induces tyrosine phosphorylation of EGFR and ␤-catenin provide further support for the potential physiological relevance of apical EGFR in gastric cells. These findings also suggest that apical EGFR may phosphorylate certain junctional proteins, such as ␤-catenin, more efficiently than basolateral receptors.
The mechanisms coupling EGFR activation to regulation of paracellular permeability remain to be unraveled. EGF-dependent tyrosine phosphorylation of ␤-catenin has previously been observed (10, 30) in a variety of transformed or immortalized cell lines. However, in these models (10, 30) , phosphorylation correlated with decreased cell adhesion or increased permeability. Our findings suggest that EGF induces tyrosine phosphorylation of ␤-catenin simultaneously with a decrease in paracellular permeability. We can only speculate that apical EGFR exert physiological regulation of paracellular permeability and that tyrosine phosphorylation of ␤-catenin plays a role in these actions of EGF. Our primary cell culture monolayers provide a model for dissecting the relevance and mechanisms of growth factor regulation of paracellular permeability via effects at the apical junctional complex. This model appears to be physiologically relevant by virtue of the presence of an apical barrier to acid that mimics this critical in vivo function of the gastric mucosa and responsiveness to regulation by growth factors.
The physiological importance of the regulation of paracellular permeability and apical EGFR remains to be determined. Our data indicate that apical EGFR on canine gastric monolayers specifically bind ligands, exhibit tyrosine kinase activity, and mediate a decrease in paracellular permeability. Other experiments in our laboratory have shown that EGF-dependent decreases in paracellular permeability correlate with increased resistance to apical acidification (unpublished observations). We postulate that apical EGFR exert physiologically relevant actions in gastric mucosa, regulating the paracellular pathway, and thereby decreasing the permeability to acid and contributing to the remarkable ability of gastric mucosal glandular cells to withstand the acidic environment of the gastric lumen.
